2007 ICD-9-CM Diagnosis Code 220 : Benign neoplasm of ovary

Home > 2007 ICD-9-CM Diagnosis Codes > Neoplasms 140-239 > Benign Neoplasms 210-229 > Benign neoplasm of ovary 220-

2007 ICD-9-CM Diagnosis Code 220

Benign neoplasm of ovary

Short description: BENIGN NEOPLASM OVARY.
ICD-9-CM 220 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 220 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
You are viewing the 2007 version of ICD-9-CM 220.
More recent version(s) of ICD-9-CM 220: 2008 2009 2010 2011 2012 2013 2014 2015.

Convert to ICD-10-CM: 220 converts approximately to:

2015/16 ICD-10-CM D27.9 Benign neoplasm of unspecified ovary

Approximate Synonyms

Benign (not cancer) neoplasm of ovary
Benign (not cancer) neoplasm, left ovary
Benign (not cancer) neoplasm, right ovary
Benign neoplasm of left ovary
Benign neoplasm of right ovary
Benign neoplasm ovary, teratoma
Benign neoplasm, L ovary
Benign neoplasm, left ovary
Benign neoplasm, ovary
Benign neoplasm, R ovary
Benign neoplasm, right ovary
Brenner tumor of ovary
Brenner tumor, ovary
Cyst ovary, dermoid
Cystadenoma of ovary, mucinous
Cystadenoma of ovary, serous
Dermoid cyst of bilateral ovaries
Dermoid cyst of left ovary
Dermoid cyst of ovary
Dermoid cyst of right ovary
Dermoid cyst, bilat ovaries
Dermoid cyst, bilateral ovaries
Dermoid cyst, left ovary
Dermoid cyst, ovary
Dermoid cyst, right ovary
Fibroma of ovary
Fibroma, ovary
Mature cystic teratoma of ovary (disorder)
Mucinous cystadenoma of ovary
Mucinous cystadenoma, ovary
Ovarian Brenner tumor
Ovarian fibroma
Serous cystadenoma of ovary
Serous cystadenoma, ovary
Teratoma of ovary
Teratoma, ovary

220 Excludes

cyst:
- corpus albicans (620.2)
- corpus luteum (620.1)
- endometrial (617.1)
- follicular (atretic) (620.0)
- graafian follicle (620.0)
- ovarian NOS (620.2)
- retention (620.2)

Use Additional

Use additional code to identify any functional activity (256.0-256.1)

ICD-9-CM Volume 2 Index entries containing back-references to 220:

Adenofibroma (M9013/0)
- endometrioid (M8381/0) 220
  - borderline malignancy (M8381/1) 236.2
  - malignant (M8381/3) 183.0
- mucinous (M9015/0)
  - specified site - see Neoplasm, by site, benign
  - unspecified site 220
- serous (M9014/0)
  - specified site - see Neoplasm, by site, benign
  - unspecified site 220
- unspecified site 220
Adenoma (sessile) (M8140/0) - see also Neoplasm, by site, benign
- Pick's tubular (M8640/0)
  - specified site - see Neoplasm, by site, benign
  - unspecified site
    - female 220
    - male 222.0
- Sertoli cell (M8640/0)
  - specified site - see Neoplasm, by site, benign
  - unspecified site
    - female 220
    - male 222.0
- testicular (M8640/0)
  - specified site - see Neoplasm, by site, benign
  - unspecified site
    - female 220
    - male 222.0
- tubular (M8211/0) - see also Neoplasm, by site, benign
  - papillary (M8460/3)
  - Pick's (M8640/0)
    - specified site - see Neoplasm, by site, benign
    - unspecified site
      - female 220
      - male 222.0
Androblastoma (M8630/1)
- benign (M8630/0)
  - specified site - see Neoplasm, by site, benign
  - unspecified site
    - female 220
    - male 222.0
- tubular (M8640/0)
  - with lipid storage (M8641/0)
    - specified site - see Neoplasm, by site, benign
    - unspecified site
      - female 220
      - male 222.0
  - specified site - see Neoplasm, by site, benign
  - unspecified site
    - female 220
    - male 222.0
Arrhenoblastoma (M8630/1)
- benign (M8630/0)
  - specified site - see Neoplasm, by site, benign
  - unspecified site
    - female 220
    - male 222.0
Brenner's
- tumor (benign) (M9000/0) 220
  - borderline malignancy (M9000/1) 236.2
  - malignant (M9000/3) 183.0
  - proliferating (M9000/1) 236.2
  - myocardial 746.85
Carcinoid (tumor) (M8240/1) - see also Neoplasm, by site, uncertain behavior
- benign (M9091/0) 220
Cyst (mucus) (retention) (serous) (simple)
- ovary, ovarian (twisted) 620.2
  - adherent 620.2
  - chocolate 617.1
  - corpus
    - albicans 620.2
    - luteum 620.1
  - dermoid (M9084/0) 220
  - developmental 752.0
  - due to failure of involution NEC 620.2
  - endometrial 617.1
  - follicular (atretic) (graafian) (hemorrhagic) 620.0
  - hemorrhagic 620.2
  - in pregnancy or childbirth 654.4
    - affecting fetus or newborn 763.89
    - causing obstructed labor 660.2
      - affecting fetus or newborn 763.1
  - multilocular (M8000/1) 239.5
  - pseudomucinous (M8470/0) 220
  - retention 620.2
  - serous 620.2
  - theca lutein 620.2
  - tuberculous (see also Tuberculosis) 016.6
  - unspecified 620.2
- pseudomucinous (ovary) (M8470/0) 220
Cystadenofibroma (M9013/0)
- endometrioid (M8381/0) 220
  - borderline malignancy (M8381/1) 236.2
  - malignant (M8381/3) 183.0
- mucinous (M9015/0)
  - specified site - see Neoplasm, by site, benign
  - unspecified site 220
- serous (M9014/0)
  - specified site - see Neoplasm, by site, benign
  - unspecified site 220
- unspecified site 220
Cystadenoma (M8440/0) - see also Neoplasm, by site, benign
- mucinous (M8470/0)
  - borderline malignancy (M8470/1)
    - specified site - see Neoplasm, uncertain behavior
    - unspecified site 236.2
  - papillary (M8471/0)
    - borderline malignancy (M8471/1)
      - specified site - see Neoplasm, by site, uncertain behavior
      - unspecified site 236.2
    - specified site - see Neoplasm, by site, benign
    - unspecified site 220
  - specified site - see Neoplasm, by site, benign
  - unspecified site 220
- papillary (M8450/0)
  - borderline malignancy (M8450/1)
    - specified site - see Neoplasm, by site, uncertain behavior
    - unspecified site 236.2
  - lymphomatosum (M8561/0) 210.2
  - mucinous (M8471/0)
    - borderline malignancy (M8471/1)
      - specified site - see Neoplasm, by site, uncertain behavior
      - unspecified site 236.2
    - specified site - see Neoplasm, by site, benign
    - unspecified site 220
  - pseudomucinous (M8471/0)
    - borderline malignancy (M8471/1)
      - specified site - see Neoplasm, by site uncertain behavior
      - unspecified site 236.2
    - specified site - see Neoplasm, by site, benign
    - unspecified site 220
  - serous (M8460/0)
    - borderline malignancy (M8460/1)
      - specified site - see Neoplasm, by site, uncertain behavior
      - unspecified site 236.2
    - specified site - see Neoplasm, by site, benign
    - unspecified site 220
  - specified site - see Neoplasm, by site, benign
  - unspecified site 220
- pseudomucinous (M8470/0)
  - borderline malignancy (M8470/1)
    - specified site - see Neoplasm, by site uncertain behavior
    - unspecified site 236.2
  - papillary (M8471/0)
    - borderline malignancy (M8471/1)
      - specified site - see Neoplasm, by site uncertain behavior
      - unspecified site 236.2
    - specified site - see Neoplasm, by site, benign
    - unspecified site 220
  - specified site - see Neoplasm, by site, benign
  - unspecified site 220
- serous (M8441/0)
  - borderline malignancy (M8441/1)
    - specified site - see Neoplasm, by site, uncertain behavior
    - unspecified site 236.2
  - papillary (M8460/0)
    - borderline malignancy (M8460/1)
      - specified site - see Neoplasm, by site, uncertain behavior
      - unspecified site 236.2
    - specified site - see Neoplasm, by site, benign
    - unspecified site 220
  - specified site - see Neoplasm, by site, benign
  - unspecified site 220
Cystoma (M8440/0) - see also Neoplasm, by site, benign
- mucinous (M8470/0)
  - specified site - see Neoplasm, by site, benign
  - unspecified site 220
- serous (M8441/0)
  - specified site - see Neoplasm, by site, benign
  - unspecified site 220
Leydig cell
- tumor (M8650/1)
  - benign (M8650/0)
    - specified site - see Neoplasm, by site, benign
    - unspecified site
      - female 220
      - male 222.0
  - malignant (M8650/3)
    - specified site - see Neoplasm, by site, malignant
    - unspecified site
      - female 183.0
      - male 186.9
  - specified site - see Neoplasm, by site, uncertain behavior
  - unspecified site
    - female 236.2
    - male 236.4
Leydig-Sertoli cell tumor (M8631/0)
- unspecified site
  - female 220
  - male 222.0
Luteinoma (M8610/0) 220
Luteoma (M8610/0) 220
Masculinovoblastoma (M8670/0) 220
Papilloma (M8050/0) - see also Neoplasm, by site, benign
- serous surface (M8461/0)
  - borderline malignancy (M8461/1)
    - specified site - see Neoplasm, by site, uncertain behavior
    - unspecified site 236.2
  - specified site - see Neoplasm, by site, benign
  - unspecified site 220
Pick's
- tubular adenoma (M8640/0)
  - specified site - see Neoplasm, by site, benign
  - unspecified site
    - female 220
    - male 222.0
Pseudomucinous
- cyst (ovary) (M8470/0) 220
Sertoli cell
- adenoma (M8640/0)
  - specified site - see Neoplasm, by site, benign
  - unspecified site
    - female 220
    - male 222.0
- tumor (M8640/0)
  - with lipid storage (M8641/0)
    - specified site - see Neoplasm, by site, benign
    - unspecified site
      - female 220
      - male 222.0
  - specified site - see Neoplasm, by site, benign
  - unspecified site
    - female 220
    - male 222.0
Sertoli-Leydig cell tumor (M8631/0)
- unspecified site
  - female 220
  - male 222.0
Struma (see also Goiter) 240.9
- ovarii (M9090/0) 220
  - and carcinoid (M9091/1) 236.2
  - malignant (M9090/3) 183.0
Teratoma (solid) (M9080/1) - see also Neoplasm, by site, uncertain behavior
- ovary (M9080/0) 220
  - embryonal, immature, or malignant (M9080/3) 183.0
Thecoma (M8600/0) 220
- malignant (M8600/3) 183.0
Tumor (M8000/1) - see also Neoplasm, by site, unspecified nature
- brenner (M9000/0) 220
  - borderline malignancy (M9000/1) 236.2
  - malignant (M9000/3) 183.0
  - proliferating (M9000/1) 236.2
- hilar cell (M8660/0) 220
- Leydig cell (M8650/1)
  - benign (M8650/0)
    - specified site - see Neoplasm, by site, benign
    - unspecified site
      - female 220
      - male 222.0
  - malignant (M8650/3)
    - specified site - see Neoplasm, by site, malignant
    - unspecified site
      - female 183.0
      - male 186.9
  - specified site - see Neoplasm, by site, uncertain behavior
  - unspecified site
    - female 236.2
    - male 236.4
- lipid cell, ovary (M8670/0) 220
- lipoid cell, ovary (M8670/0) 220
- Sertoli cell (M8640/0)
  - with lipid storage (M8641/0)
    - specified site - see Neoplasm, by site, benign
    - unspecified site
      - female 220
      - male 222.0
  - specified site - see Neoplasm, by site, benign
  - unspecified site
    - female 220
    - male 222.0
- Sertoli-Leydig cell (M8631/0)
  - specified site, - see Neoplasm, by site, benign
  - unspecified site
    - female 220
    - male 222.0
- theca cell (M8600/0) 220
- theca-lutein (M8610/0) 220

219.9

ICD9Data.com

221

ICD-9-CM codes are used in medical billing and coding to describe diseases, injuries, symptoms and conditions. ICD-9-CM 220 is one of thousands of ICD-9-CM codes used in healthcare. Although ICD-9-CM and CPT codes are largely numeric, they differ in that CPT codes describe medical procedures and services. Can't find a code? Start at the root of ICD-9-CM, check the 2007 ICD-9-CM Index or use the search engine at the top of this page to lookup any code.

Free ICD-9-CM Codes

Site Information

About · Privacy Policy · Disclaimer

Free ICD-10-CM/PCS Codes

Free HCPCS Codes

2016 · 2015 · 2014 · 2013 · 2012
2011 · 2010 · 2009 · 2008